| 2023-02-02 | Sale | Viridian Therapeutics, Inc. VRDN | Chief Executive Officer | 50,000 0.1224% | $36.80 | $1.84M | -41.26% | |
| 2022-06-01 | Sale | Viridian Therapeutics, Inc. VRDN | Chief Executive Officer | 30,000 0.1086% | $12.20 | $366,000 | +95.88% | |
| 2022-05-02 | Sale | Viridian Therapeutics, Inc. VRDN | Chief Executive Officer | 30,000 0.1091% | $13.04 | $391,200 | +75% | |
| 2022-04-01 | Sale | Viridian Therapeutics, Inc. VRDN | Chief Executive Officer | 3,600 0.0131% | $18.93 | $68,148 | +11.11% | |
| 2022-03-02 | Sale | Viridian Therapeutics, Inc. VRDN | Chief Executive Officer | 11,106 0.0425% | $17.36 | $192,800 | +15.21% | |
| 2022-03-01 | Sale | Viridian Therapeutics, Inc. VRDN | Chief Executive Officer | 18,894 0.0731% | $17.82 | $336,691 | +13.38% | |
| 2022-02-03 | Sale | Viridian Therapeutics, Inc. VRDN | Chief Executive Officer | 909 0.0034% | $19.16 | $17,416 | +0.56% | |
| 2022-02-02 | Sale | Viridian Therapeutics, Inc. VRDN | Chief Executive Officer | 12,340 0.0471% | $18.47 | $227,920 | +6.75% | |
| 2022-02-01 | Sale | Viridian Therapeutics, Inc. VRDN | Chief Executive Officer | 16,751 0.0643% | $19.55 | $327,482 | +1.28% |